Dostarlimab Drug
Dostarlimab, The Drug That 'Cured' Cancer During Trials. As many as 18 rectal cancer patients were given the Dostarlimab drug in prescribed dosages every three weeks for six months. A study has found that a drug named Dostarlimab has helped treat rectal cancer. This has been described as a "first time in history"kind of result in cancer treatment with the disease simply vanishing in patients after the experimental treatment. Here are 10 things to know about Dostarlimab, the drug that cured cancer during trial : 1. The clinical trial comprised a group of 18 patients. All of them were battling rectal cancer at the Memorial Sloan Kettering Cancer Center in Manhattan, US. 2. In all patients, rectal cancer was locally advanced. This means the tumours had spread within the rectum and in some cases, to the lymph nodes, but not to other organs. 3. The drug named Dostarlimab was administered to the patients for a period of six months. The medicine was given in prescrib...